Contrasting effects of verapamil and nifedipine on pH of ischemic myocardium in the dog. 1989

Y M Ro, and D R Markle, and S R Goldstein, and E Speir, and R Greene, and K Steadman, and R Aamodt, and S E Epstein, and R E Patterson
Experimental Physiology and Pharmacology Section, National Heart, Lung and Blood Institute, Bethesda, Maryland.

It remains unknown whether the actions of verapamil to depress and nifedipine to enhance contractile function of ischemic myocardium influence the degree of myocardial ischemic injury. Thus, we measured intramyocardial pH using fiberoptic pH probes in 43 anesthetized open-chest dogs pretreated for 30 min with verapamil, or nifedipine in doses that decreased aortic pressure 10 to 15 mm Hg before ligation of the left anterior descending coronary artery for 15 min. Drugs were continued during the 15-min ischemic period until the animals were euthanized without reperfusion: verapamil, 10-20 micrograms/kg/min and nifedipine, 2 to 4 micrograms/kg/min i.v. Verapamil-treated dogs showed higher pH of ischemic subendocardium after 15 min ischemia (6.75 +/- 0.07) than did the nifedipine (6.48 +/- 0.04) or placebo (6.43 +/- 0.05) groups, even if the animals were paced (6.71 +/- 0.11) to prevent the negative chronotropic effect of verapamil (P less than 0.01). Neither verapamil nor nifedipine changed collateral myocardial blood flow from 0.10 +/- 0.02 in the subendocardium and 0.17 +/- 0.03 ml/min/g in the subepicardium. Left ventricular function estimated by left ventricular dp/dt was depressed 15% by verapamil and enhanced 26% by nifedipine. Thus, verapamil, but not nifedipine, relieves acidosis of ischemic myocardium after acute coronary occlusion in doses that sustain a 10 to 15 mm Hg decrease in aortic pressure. Nifedipine, in doses that produced the same 10 to 15 mm Hg decrease in mean aortic pressure, did not increase intramyocardial pH, as it enhanced contractile function, estimated by left ventricular dp/dt.(ABSTRACT TRUNCATED AT 250 WORDS)

UI MeSH Term Description Entries
D009200 Myocardial Contraction Contractile activity of the MYOCARDIUM. Heart Contractility,Inotropism, Cardiac,Cardiac Inotropism,Cardiac Inotropisms,Contractilities, Heart,Contractility, Heart,Contraction, Myocardial,Contractions, Myocardial,Heart Contractilities,Inotropisms, Cardiac,Myocardial Contractions
D009206 Myocardium The muscle tissue of the HEART. It is composed of striated, involuntary muscle cells (MYOCYTES, CARDIAC) connected to form the contractile pump to generate blood flow. Muscle, Cardiac,Muscle, Heart,Cardiac Muscle,Myocardia,Cardiac Muscles,Heart Muscle,Heart Muscles,Muscles, Cardiac,Muscles, Heart
D009543 Nifedipine A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure. Adalat,BAY-a-1040,Bay-1040,Cordipin,Cordipine,Corinfar,Fenigidin,Korinfar,Nifangin,Nifedipine Monohydrochloride,Nifedipine-GTIS,Procardia,Procardia XL,Vascard,BAY a 1040,BAYa1040,Bay 1040,Bay1040,Monohydrochloride, Nifedipine,Nifedipine GTIS
D003326 Coronary Circulation The circulation of blood through the CORONARY VESSELS of the HEART. Circulation, Coronary
D003327 Coronary Disease An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels. Coronary Heart Disease,Coronary Diseases,Coronary Heart Diseases,Disease, Coronary,Disease, Coronary Heart,Diseases, Coronary,Diseases, Coronary Heart,Heart Disease, Coronary,Heart Diseases, Coronary
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D006439 Hemodynamics The movement and the forces involved in the movement of the blood through the CARDIOVASCULAR SYSTEM. Hemodynamic
D006863 Hydrogen-Ion Concentration The normality of a solution with respect to HYDROGEN ions; H+. It is related to acidity measurements in most cases by pH pH,Concentration, Hydrogen-Ion,Concentrations, Hydrogen-Ion,Hydrogen Ion Concentration,Hydrogen-Ion Concentrations
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014700 Verapamil A calcium channel blocker that is a class IV anti-arrhythmia agent. Iproveratril,Calan,Cordilox,Dexverapamil,Falicard,Finoptin,Isoptin,Isoptine,Izoptin,Lekoptin,Verapamil Hydrochloride,Hydrochloride, Verapamil

Related Publications

Y M Ro, and D R Markle, and S R Goldstein, and E Speir, and R Greene, and K Steadman, and R Aamodt, and S E Epstein, and R E Patterson
January 1990, The American journal of cardiovascular pathology,
Y M Ro, and D R Markle, and S R Goldstein, and E Speir, and R Greene, and K Steadman, and R Aamodt, and S E Epstein, and R E Patterson
December 1983, American heart journal,
Y M Ro, and D R Markle, and S R Goldstein, and E Speir, and R Greene, and K Steadman, and R Aamodt, and S E Epstein, and R E Patterson
June 1985, Journal of the American College of Cardiology,
Y M Ro, and D R Markle, and S R Goldstein, and E Speir, and R Greene, and K Steadman, and R Aamodt, and S E Epstein, and R E Patterson
January 1984, Renal physiology,
Y M Ro, and D R Markle, and S R Goldstein, and E Speir, and R Greene, and K Steadman, and R Aamodt, and S E Epstein, and R E Patterson
January 1984, Journal of cardiovascular pharmacology,
Y M Ro, and D R Markle, and S R Goldstein, and E Speir, and R Greene, and K Steadman, and R Aamodt, and S E Epstein, and R E Patterson
January 1988, Ceskoslovenska fysiologie,
Y M Ro, and D R Markle, and S R Goldstein, and E Speir, and R Greene, and K Steadman, and R Aamodt, and S E Epstein, and R E Patterson
January 1987, Cardiovascular research,
Y M Ro, and D R Markle, and S R Goldstein, and E Speir, and R Greene, and K Steadman, and R Aamodt, and S E Epstein, and R E Patterson
August 1980, The American journal of cardiology,
Y M Ro, and D R Markle, and S R Goldstein, and E Speir, and R Greene, and K Steadman, and R Aamodt, and S E Epstein, and R E Patterson
February 1981, Circulation research,
Y M Ro, and D R Markle, and S R Goldstein, and E Speir, and R Greene, and K Steadman, and R Aamodt, and S E Epstein, and R E Patterson
January 1985, Advances in myocardiology,
Copied contents to your clipboard!